Biodexa Announces Recruitment of First Patient in Phase 2 Study of Tolimidone in Type 1 Diabetes Biodexa Pharmaceuticals PLC ...

Original-Research: Sernova Biotherapeutics Inc - from First Berlin Equity Research GmbH02.06.2025 / 13:39 CET/CESTDissemination of a Research, transmitted by EQS News - a service of EQS Group.The ...

An oral therapy to treat Wolfram syndrome significantly improved pancreatic functions and induced improvement in symptoms at ...

Wenzhou Medical University researchers have reimagined the spleen as a viable site for islet transplantation, enabling ...

The test cited in the West Virginia legislation — known as a “c-peptide” test — can measure insulin, Uribe said, but timing is key: It has to be conducted before doctors provide treatment ...

Vertex has been conducting a phase 1/2 study of this cell and device approach to measure whether it led to an increase in peak C-peptide—a biomarker of insulin production—in individuals with ...

“The C-peptide data which was presented during ATTD is a meaningful update, as we now have insight into why insulin-deficient patients may respond better to icovamenib treatment. The potential to ...

“At ATTD, we presented data on icovamenib’s ability to drive a significant increase in C-peptide production in ... enabling them to produce more insulin on their own and take back control ...

Biomarkers of glucose metabolism, such as C-peptide, glycated hemoglobin (HbA1c), and insulin, were assessed. Participants were followed up until the last questionnaire, T2D diagnosis, death ...

Why It’s Done How It’s Performed What’s Next The C-peptide test is a way of estimating how much of the hormone insulin your body creates. This test can help doctors determine what type of ...

The C-peptide test is a way of estimating how much of the hormone insulin your body creates. This test can help doctors determine what type of diabetes you have. It can also help show how far your ...

In the 12-week study of 57 people with T2D who were not using insulin, C-peptide levels were significantly higher among those randomized to receive a low-carbohydrate diet (~9% of total calories ...